Behavioral sensitization to amphetamine is not accompanied by a decrease in the number of c-Fos containing cells in the striatum

Brain Research

Volumn 782, Issue 1-2, 1998, Pages 329-332

  Turgeon, Sarah M ^a   Blum, Jennifer E ^a   Auerbach, Eliza A ^a  

^a AMHERST COLLEGE   (United States)

Author keywords

Amphetamine; Behavioral sensitization; c Fos; Dopamine; FRA; Immunohistochemistry; Striatum

Indexed keywords

AMPHETAMINE; ANTIBODY; PROTEIN C FOS;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BEHAVIOR; CONTROLLED STUDY; CORPUS STRIATUM; CROSS REACTION; IMMUNOHISTOCHEMISTRY; MALE; NONHUMAN; ONCOGENE C FOS; PRIORITY JOURNAL; RAT; SENSITIZATION;

AMPHETAMINE; ANIMALS; BEHAVIOR, ANIMAL; CELL COUNT; CENTRAL NERVOUS SYSTEM STIMULANTS; CORPUS STRIATUM; MALE; NEURONS; PROTO-ONCOGENE PROTEINS C-FOS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0032567804     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(97)01376-0     Document Type: Article

References (22)

1. Curran E.J., Akil H., Watson S. Psychomotor stimulant- and opiate-induced c-fos mRNA expression patterns in the rat forebrain: Comparisons between acute drug treatment and a drug challenge in sensitized animals. Neurochem. Res. 21:1996;1425-1435.
2. Graybiel A.M., Moratalla R., Robertson H.A. Amphetamine and cocaine induce drug-specific activation of the c-fos gene in striosome-matrix compartments and limbic subdivisions of the striatum. Proc. Natl. Acad. Sci. U.S.A. 87:1990;6912-6916.
3. Hurd Y.L., Lindefors N., Brodin E., Brene S., Persson H., Ungerstedt U., Hokfelt T. Amphetamine regulation of mesolimbic dopamine/cholecystokinin neurotransmission. Brain Res. 578:1992;317-326.
4. Imperato A., Obinu M.C., Carta G., Mascia M.S., Casu M.A., Gessa G.L. Reduction of dopamine release and synthesis by repeated amphetamine treatment: Role in behavioral sensitization. Eur. J. Pharmacol. 317:1996;231-237.
5. Jaber M., Cador M., Dumartin B., Normand E., Stinus L., Bloch B. Acute and chronic amphetamine treatments differently regulate neuropeptide messenger RNA levels and fos immunoreactivity in rat striatal neurons. Neuroscience. 65:1995;1041-1050.
6. Jackson D.M., Bailey R.C., Macdonald J.C., Crisp E.A., Skerritt J.H. Long-term D-amphetamine in rats: Lack of change in postsynaptic dopamine receptor sensitivity. Psychopharmacology. 73:1981;276-280.
7. Kalivas P.W., Stewart J. Dopamine transmission in the initiation and expression of drug- and stress-induced sensitization of motor activity. Brain Res. Rev. 16:1991;223-244.
8. Kalivas P.W., Weber B. Amphetamine injection into the ventral mesencephalon sensitizes rats to peripheral amphetamine and cocaine. J. Pharmacol. Exp. Ther. 245:1988;1095-1102.
9. Klawans H.L., Margolin D.I. Amphetamine-induced dopaminergic hypersensitivity in guinea pigs. Arch. Gen. Psychiatry. 32:1975;725-732.
10. Patrick S.L., Thompson T.L., Walker J.M., Patrick R.L. Concomitant sensitization of amphetamine-induced behavioral stimulation and in vivo dopamine release from rat caudate nucleus. Brain Res. 538:1991;343-346.
11. G. Paxinos, C. Watson, The Rat Brain in Stereotaxic Coordinates, 2nd edn., Academic Press, San Diego, 1986.
12. Persico A.M., Schindler C.W., O'Hara B.F., Brannock M.T., Uhl G.R. Brain transcription factor expression: Effects of acute and chronic amphetamine and injection stress. Mol. Brain Res. 20:1993;91-100.
13. Robinson T.E., Becker J. Enduring changes in brain and behavior produced by chronic amphetamine administration: A review and evaluation of animal models of amphetamine psychosis. Brain Res. Rev. 11:1986;157-198.
14. Robinson T.E., Jurson P.A., Bennett J.A., Bentgen K.M. Persistent sensitization of dopamine neurotransmission in ventral striatum (nucleus accumbens) produced by prior experience with (+)-amphetamine: A microdialysis study in freely moving rats. Brain Res. 462:1988;211-222.
15. Segal D.S., Kuczenski R. In vivo microdialysis reveals a diminished amphetamine-induced DA response corresponding to behavioral sensitization produced by repeated amphetamine pretreatment. Brain Res. 571:1992;330-337.
16. Simpson J.N., Wang J.Q., McGinty J.F. Repeated amphetamine administration induces a prolonged augmentation of phosphorylated cylase response element-binding protein and fos-related antigen immunoreactivity in rat striatum. Neuroscience. 69:1995;441-457.
17. Stewart J., Vezina P. Microinjections of Sch-23390 into the ventral tegmental area and substantia nigra pars reticulata attenuate the development of sensitization to the locomotor activating effects of systemic amphetamine. Brain Res. 495:1989;401-406.
18. Strakowski S.M., Sax K.W., Setters M.J., Keck P.E. Enhanced response to repeated D-amphetamine challenge: Evidence for behavioral sensitization in humans. Biol. Psychiatry. 40:1996;872-880.
19. Turgeon S.M., Pollack A.E., Fink J.S. Enhanced CREB phosphorylation and changes in c-Fos and FRA expression in striatum accompany amphetamine sensitization. Brain Res. 749:1997;120-126.
20. Vezina P., Stewart J. Amphetamine administered to the ventral tegmental area but not to the nucleus accumbens sensitizes rats to systemic morphine: Lack of conditioned effects. Brain Res. 516:1990;99-106.
21. Wang J.Q., McGinty J.F. Alterations in striatal zif/268, preprodynorphin and preproenkephalin mRNA expression induced by repeated amphetamine administration in rats. Brain Res. 673:1995;263-274.
22. Wolf M.E., White F.J., Nassar R., Brooderson R.J., Khansa M.R. Differential development of autoreceptor subsensitivity and enhanced dopamine release during amphetamine sensitization. J. Pharmacol. Exp. Ther. 264:1993;249-264.